Autoantibodies with Enzymatic Properties in Human Autoimmune Diseases

Overview

Journal J Autoimmun

Specialty Allergy & Immunology

Date 2011 Jun 1

PMID 21624820

Citations 16

Authors

Bharath Wootla

Sebastien Lacroix-Desmazes

Arthur E Warrington

Allan J Bieber

Srini V Kaveri

Moses Rodriguez

Affiliations

Soon will be listed here.

Abstract

Immunoglobulins (Ig) or antibodies are heavy plasma proteins, with sugar chains added to amino acid residues by N-linked glycosylation and occasionally by O-linked glycosylation. The versatility of antibodies is demonstrated by the various functions that they mediate such as neutralization, agglutination, fixation with activation of complement and activation of effector cells. In addition to this plethora of functions, some antibodies express enzymatic activity. Antibodies endowed with enzymatic properties have been described in human autoimmune manifestations in a variety of disorders such as autoimmune thyroiditis, systemic erythematosus (SLE), scleroderma, rheumatoid arthritis (RA), multiple sclerosis (MS) and acquired hemophilia (AH). Antibodies isolated from these conditions were able to specifically hydrolyze thyroglobulin, DNA, RNA, myelin basic protein (MBP), and factor VIII (FVIII) or factor IX (FIX), respectively. The therapeutic relevance of these findings is discussed.

Citing Articles

Occurrence of protease-like catalytic activity in the polyclonal IgG in schizophrenia and bipolar disorder.

Ramesh R, Sundaresh A, Rajkumar R, Negi V, Vijayalakshmi M, Kamalanathan A Sci Rep. 2024; 14(1):27970.

PMID: 39543211 PMC: 11564965. DOI: 10.1038/s41598-024-75200-y.

Cellular and Immunological Analysis of 2D2/Th Hybrid Mice Prone to Experimental Autoimmune Encephalomyelitis in Comparison with 2D2 and Th Lines.

Aulova K, Urusov A, Chernyak A, Toporkova L, Chicherina G, Buneva V Int J Mol Sci. 2024; 25(18).

PMID: 39337388 PMC: 11432411. DOI: 10.3390/ijms25189900.

Autoantibodies-Abzymes with Phosphatase Activity in Experimental Autoimmune Encephalomyelitis Mice.

Urusov A, Aulova K, Nevinsky G Molecules. 2024; 29(6).

PMID: 38543019 PMC: 10975087. DOI: 10.3390/molecules29061382.

Hydrolysis of Oligodeoxyribonucleotides on the Microarray Surface and in Solution by Catalytic Anti-DNA Antibodies in Systemic Lupus Erythematosus.

Novikova T, Ermakov E, Kostina E, Sinyakov A, Sizikov A, Nevinsky G Curr Issues Mol Biol. 2023; 45(12):9887-9903.

PMID: 38132463 PMC: 10742339. DOI: 10.3390/cimb45120617.

Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesion.

Yeruva S, Stangner K, Jungwirth A, Hiermaier M, Shoykhet M, Kugelmann D Cell Mol Life Sci. 2023; 80(8):203.

PMID: 37450050 PMC: 10348947. DOI: 10.1007/s00018-023-04853-1.

References

Mackay I . Clustering and commonalities among autoimmune diseases. J Autoimmun. 2009; 33(3-4):170-7. DOI: 10.1016/j.jaut.2009.09.006. View

Chang C, Gershwin M . Drugs and autoimmunity--a contemporary review and mechanistic approach. J Autoimmun. 2009; 34(3):J266-75. DOI: 10.1016/j.jaut.2009.11.012. View

Wentworth Jr P, McDunn J, Wentworth A, Takeuchi C, Nieva J, Jones T . Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002; 298(5601):2195-9. DOI: 10.1126/science.1077642. View

Youinou P, Pers J, Gershwin M, Shoenfeld Y . Geo-epidemiology and autoimmunity. J Autoimmun. 2010; 34(3):J163-7. DOI: 10.1016/j.jaut.2009.12.005. View

Shapira Y, Agmon-Levin N, Shoenfeld Y . Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun. 2009; 34(3):J168-77. DOI: 10.1016/j.jaut.2009.11.018. View

Rubtsov A, Rubtsova K, Kappler J, Marrack P . Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. 2010; 9(7):494-8. PMC: 3171140. DOI: 10.1016/j.autrev.2010.02.008. View

Lacroix-Desmazes S, Bayry J, Misra N, Horn M, Villard S, Pashov A . The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med. 2002; 346(9):662-7. DOI: 10.1056/NEJMoa011979. View

Yaniv I, Ash S, Farkas D, Askenasy N, Stein J . Consideration of strategies for hematopoietic cell transplantation. J Autoimmun. 2009; 33(3-4):255-9. DOI: 10.1016/j.jaut.2009.09.002. View

REUSSI C, Altman R, Rouvier J, Maino R . Combined factor VIII and IX inhibitors in a girl. Thromb Diath Haemorrh. 1966; 16(3):549-58. View

10.

Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P . Autoantibody-catalyzed hydrolysis of amyloid beta peptide. J Biol Chem. 2007; 283(8):4714-22. DOI: 10.1074/jbc.M707983200. View

11.

Youinou P . Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun. 2010; 35(3):171-5. DOI: 10.1016/j.jaut.2010.06.003. View

12.

Wootla B, Dasgupta S, Dimitrov J, Bayry J, Levesque H, Borg J . Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia. J Immunol. 2008; 180(11):7714-20. DOI: 10.4049/jimmunol.180.11.7714. View

13.

Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J . Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J Immunol. 2006; 177(2):1355-63. DOI: 10.4049/jimmunol.177.2.1355. View

14.

Pollack S, Jacobs J, Schultz P . Selective chemical catalysis by an antibody. Science. 1986; 234(4783):1570-3. DOI: 10.1126/science.3787262. View

15.

Paul S, Volle D, Beach C, Johnson D, Powell M, Massey R . Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science. 1989; 244(4909):1158-62. DOI: 10.1126/science.2727702. View

16.

Lu Q, Renaudineau Y, Cha S, Ilei G, Brooks W, Selmi C . Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun Rev. 2010; 9(9):627-30. DOI: 10.1016/j.autrev.2010.05.011. View

17.

Mackay I, Leskovsek N, Rose N . The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun. 2010; 35(3):199-205. DOI: 10.1016/j.jaut.2010.06.008. View

18.

Baranovskii A, Ershova N, Buneva V, Kanyshkova T, Mogelnitskii A, Doronin B . Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett. 2001; 76(3):163-7. DOI: 10.1016/s0165-2478(01)00185-7. View

19.

Brooks W, Le Dantec C, Pers J, Youinou P, Renaudineau Y . Epigenetics and autoimmunity. J Autoimmun. 2010; 34(3):J207-19. DOI: 10.1016/j.jaut.2009.12.006. View

20.

Paul S, Li L, Kalaga R, Stevens F, Solomon A . Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment. J Biol Chem. 1995; 270(25):15257-61. DOI: 10.1074/jbc.270.25.15257. View